DS Group, which is a prominent player in food and beverages, dairy, and hospitality, views this acquisition as a chance to make its financial services presence larger. Diversified group presence in ...
The French Navy (Marine Nationale) conducted a set of trials with Exail’s DriX USV off the coast of Toulon and tested it in the latest “Dragoon Fury” unmanned systems exercise. Continuing its ...
As a first-line therapy, DS-1062/Keytruda had an ORR of 62%, compared to 50% with triple therapy with chemo, with a disease control rate (DCR) or 100% and 90%, respectively.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback